GlassScriptPhysician profile
Lyndon B Gaines
NPI 1225075260
$2,888.48
in general payments reported to CMS, 2019-2025
22 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $1,903 · 2021: $67.00 · 2022: $56.94 · 2023: $280 · 2024: $189 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,767.18 | 2020 | |
| Abbvie INC. | $226.40 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $136.71 | 2023-2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $133.18 | 2019-2025 | |
| Pfizer INC. | $91.11 | 2019-2023 | |
| Sage Therapeutics, LLC | $88.80 | 2024-2025 | Zurzuvae |
| Abbott Laboratories | $70.78 | 2022-2024 | Freestyle Libre 3 |
| Organon LLC | $70.18 | 2021-2023 | Nexplanon |
| Glaxosmithkline, LLC. | $54.16 | 2020 | |
| Astellas Pharma US INC | $38.25 | 2025 | Veozah |
| Novo Nordisk INC | $28.31 | 2025 | Wegovy |
| Minerva Surgical, INC | $25.23 | 2019-2023 | |
| Meditrina | $24.95 | 2023 | |
| Conmed Corporation | $18.82 | 2025 | Airseal |
| Merck Sharp & Dohme LLC | $16.81 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $16.32 | 2024 | Injectafer |
| Exact Sciences Corporation | $15.13 | 2024 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $14.83 | 2025 | Collagenase Santyl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.80 | 2023 | Trulance, Xifaxan |
| Therapeuticsmd, INC. | $13.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.44 | 2019 | |
| Avion Pharmaceuticals | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyndon Gaines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.